Press release Biocartis Group NV: Biocartis’ Idylla™ SARS-CoV-2 testing Successfully Detects Omicron Variant
December 09, 2021 01:00 ET
|
Biocartis NV
PRESS RELEASE: 9 December 2021, 07:00 CET Biocartis’ Idylla™ SARS-CoV-2 testing Successfully Detects Omicron Variant Mechelen, Belgium, 9 December 2021 – Biocartis Group NV (the ‘Company’ or...
Achiko’s Commercialization Update: Optimized Second-Generation Covid-19 Diagnostic Test Receives Full Product Registration Approval in Indonesia
December 08, 2021 07:50 ET
|
Achiko AG
Second-generation of AptameX, Achiko’s innovative DNA aptamer diagnostic test for Covid-19 has received full approval in Indonesia for five yearsProduction of the second-generation AptameX kits to...
BioNTech gibt virtuelle Pressekonferenz zu Omikron-Variante
December 08, 2021 07:15 ET
|
BioNTech SE
MAINZ, Deutschland, 8. Dezember 2021 – BioNTech SE (Nasdaq: BNTX, „BioNTech” oder „das Unternehmen“) wird am Mittwoch, den 8. Dezember 2021, eine virtuelle Pressekonferenz abhalten, um die Ergebnisse...
BioNTech to Hold Digital Press Conference to Provide an Update on Omicron Variant
December 08, 2021 07:15 ET
|
BioNTech SE
MAINZ, Germany, December 8, 2021 – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will hold a digital press conference on Wednesday, December 8, 2021, to present the results from initial...
Pfizer und BioNTech geben Update zur Omikron-Variante
December 08, 2021 06:56 ET
|
BioNTech SE
Vorläufige Ergebnisse von Laboruntersuchungen zeigen, dass drei Impfdosen des Pfizer-BioNTech COVID-19-Impfstoffs die Omikron-Variante (B.1.1.529) neutralisieren, wohingegen zwei Impfdosen signifikant...
Pfizer and BioNTech Provide Update on Omicron Variant
December 08, 2021 06:56 ET
|
BioNTech SE
Preliminary laboratory studies demonstrate that three doses of the Pfizer-BioNTech COVID-19 Vaccine neutralize the Omicron variant (B.1.1.529 lineage), while two doses show significantly reduced...
MAKO Medical Detects Three Cases of COVID-19 Omicron Variant in U.S.
December 07, 2021 08:45 ET
|
MAKO Medical
Raleigh, North Carolina, Dec. 07, 2021 (GLOBE NEWSWIRE) -- MAKO Medical Laboratories, a national reference laboratory and leader in COVID-19 testing, today announced that it has detected three cases...
Vir Biotechnology to Host a Call on Sotrovimab’s Retained Activity Against the Omicron SARS-CoV-2 Variant
December 07, 2021 03:55 ET
|
Vir Biotechnology, Inc.
SAN FRANCISCO, Dec. 07, 2021 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) announced that Management will host a conference call at 8:30 am ET, Tuesday, December 7, 2021, to discuss new...
Preclinical Studies Demonstrate Sotrovimab Retains Activity Against the Full Combination of Mutations in the Spike Protein of the Omicron SARS-CoV-2 Variant
December 07, 2021 03:48 ET
|
Vir Biotechnology, Inc.
– New preclinical findings generated through in vitro testing of sotrovimab againstthe complete pseudo-virus updated to bioRxiv – Data build on promising signal published last week, underscoring the...
iHealth Statement on the COVID-19 Omicron Variant and Its At-Home Test Kit's Effectiveness
December 02, 2021 17:37 ET
|
iHealth Labs Inc
SUNNYVALE, Calif., Dec. 02, 2021 (GLOBE NEWSWIRE) -- iHealth Labs Inc., a leader in the design and manufacturing of consumer-friendly, mobile personal healthcare products, issued the following...